semaglutide weight loss grayhawk (Ozempic® & Wegovy®) Before and After Results: Timelines (2026) Weight Loss Results after 4-5

Darrell V

Discover how microdosing GLP-1s can have low side effects, low costs, and support weight loss

Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once.

The surge in demand for GLP-1 medications for weight loss has shifted how healthcare providers approach weight management conversations.

The pharmaceutical ecosystem currently faces a structural realignment of unprecedented magnitude

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics.